highly significantP = 0.002
fat percentage) ( P = 0.00001) and no effect when the outcome was BMI; the difference in results was highly significant ( P = 0.002).
fat percentage) ( P = 0.00001) and no effect when the outcome was BMI; the difference in results was highly significant ( P = 0.002).
Additional medications used but not FDA-approved for the treatment of obesity Metformin decreased BMI slightly but significantly in each of the three studies analyzed, but the overall effect did not reach statistical significance in the meta-analysis ( 118 ).